Synopsis: Deepak Nitrite’s Rs 2,500 crore capex plan and new capacity ramp-ups aim to drive the next phase of growth. While volumes improve and projects progress, global pricing pressure and cautious earnings outlook continue to weigh on near-term prospects.
This article highlights Deepak Nitrite’s ongoing expansion strategy, including its Rs 2,500 crore capex plan, new capacity additions, and project ramp-ups across key chemical segments. It also reviews the company’s recent financial performance, segmental trends, industry challenges, and brokerage outlook on earnings growth and valuation.
Deepak Nitrite Limited (DNL), founded in 1970 and headquartered in Vadodara, Gujarat, is a leading Indian chemical manufacturer specializing in Basic Chemicals, Fine & Speciality Chemicals, and Performance Products. The company operates manufacturing facilities in Gujarat, Maharashtra, and Telangana, catering to diverse sectors like pharmaceuticals, agrochemicals, and dyes.
With a market capitalization of Rs 20,324 crore, the shares of the company today closed at Rs 1,490.15 per share, flat from its previous day’s close. The share of the company has given a negative return of 24 percent over the previous year, and a 5 percent negative return in the last five years
Overall Financial Performance
Deepak Group’s Q3 FY26 performance, which showed a mixed trend of higher volumes but moderately subdued margins. Consolidated revenue grew 3 percent year-on-year and quarter-on-quarter to INR 1,983 crore, while EBITDA rose 16 percent to INR 219 crore, reflecting improved operating efficiencies and disciplined cost control. For the nine months, revenue stood at INR 5,820 crore with an EBITDA of INR 658 crore, indicating stability despite challenging pricing conditions and a softer margin environment.
The company’s domestic to export revenue mix remained 83:17 in Q3, underscoring the resilience of its domestic franchise and ongoing global customer engagement. Focus on working capital efficiency through tighter inventory planning, supply chain optimization, and better receivables management supported cash flow and strengthened the balance sheet. With a return on capital employed (ROCE) of 15 percent, Deepak Group continues to demonstrate effective capital utilization while pursuing volume-led growth.
Segmental Performance: Deepak Group’s Q3 FY26 Phenolics segment showed strong performance, with revenues at INR 1,334 crore and EBIT rising 20 percent YoY to INR 145 crore, driven by higher phenol and acetone volumes, better plant utilization, and ongoing process optimization.
The Advanced Intermediates segment grew steadily, with revenue at INR 652 crore, up 18 percent YoY and 11 percent QoQ, supported by higher volumes and stronger market penetration, though EBIT remained constrained at INR 15 crore due to pricing pressures from Chinese dumping and global oversupply.
Strategic Developments & Projects: It has achieved a key milestone with the commissioning of new nitric acid, nitration, and hydrogenation plants, completing vertical integration across the ammonia-to-amines value chain. This strengthens margins, expands the downstream portfolio, and supports growth initiatives, including the MIBK/MIBC and polycarbonate projects, while accelerating the shift toward renewable energy.
Project & Capacity Ramp-up
Deepak Nitrite has allocated around Rs 100 crore toward strengthening its R&D facility, a strategic investment aimed at long-term innovation rather than immediate capacity utilization. Meanwhile, key assets such as nitration, hydrogenation, and nitric acid plants are expected to operate at near-full utilization levels of roughly 95–105 percent starting this quarter.
Other capacities, including photochemical, chlorination, and fluorination units, are expected to witness utilization improvements beginning Q1 FY27. Newly commissioned fluorination and diazotization assets will see a gradual ramp-up aligned with customer demand, indicating a phased scaling of production as order visibility improves.
The company is also investing in advanced technologies such as MIBK and MIBC production, with phased ramp-ups expected in Q1 FY27 following early seed marketing and positive customer response globally. Deepak Nitrite plans capital expenditure of about Rs 1,200–1,300 crore in FY26 and Rs 2,500 crore in FY27.
Industry & Near-Term Outlook: The global chemical industry remains under pressure due to persistent pricing challenges, strong competition, and uneven demand patterns. Aggressive pricing from Chinese producers and shifting trade flows have intensified market dynamics. Although favourable US tariff changes provide a positive long-term outlook, the company expects only a moderate impact due to limited exposure.
Earnings & Valuation: The brokerage has reduced its earnings estimates for FY26 and FY27 by 17 percent and 7 percent, respectively, while keeping FY28 projections unchanged. It expects revenue, EBITDA, and profit to grow at a CAGR of 5 percent, 9 percent, and 7 percent over FY25–FY28. Valuing the stock at 24× FY28E EPS, it maintains a Sell rating with a target price of Rs 1,470.
Conclusion: Deepak Nitrite’s Rs 2,500 crore capex and new plants are set to boost growth, improve efficiency, and expand its chemical product range. Investments in R&D and advanced projects aim to strengthen margins and support future opportunities.
Even with global pricing challenges and competition, the company’s strong domestic business, rising volumes, and careful use of capital provide stability, positioning it well for long-term growth despite near-term earnings pressure.
Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Trade Brains Technologies Private Limited or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.
